Page last updated: 2024-09-03

2-chloro-n(6)cyclopentyladenosine and 1,3-dipropylxanthine

2-chloro-n(6)cyclopentyladenosine has been researched along with 1,3-dipropylxanthine in 1 studies

Compound Research Comparison

Studies
(2-chloro-n(6)cyclopentyladenosine)
Trials
(2-chloro-n(6)cyclopentyladenosine)
Recent Studies (post-2010)
(2-chloro-n(6)cyclopentyladenosine)
Studies
(1,3-dipropylxanthine)
Trials
(1,3-dipropylxanthine)
Recent Studies (post-2010) (1,3-dipropylxanthine)
2520432600

Protein Interaction Comparison

ProteinTaxonomy2-chloro-n(6)cyclopentyladenosine (IC50)1,3-dipropylxanthine (IC50)
Adenosine receptor A1Rattus norvegicus (Norway rat)1.5

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Figler, H; Jin, X; Linden, J; Robeva, AS; Thai, T1

Other Studies

1 other study(ies) available for 2-chloro-n(6)cyclopentyladenosine and 1,3-dipropylxanthine

ArticleYear
Characterization of human A(2B) adenosine receptors: radioligand binding, western blotting, and coupling to G(q) in human embryonic kidney 293 cells and HMC-1 mast cells.
    Molecular pharmacology, 1999, Volume: 56, Issue:4

    Topics: Animals; Anti-Asthmatic Agents; Blotting, Western; Calcium; Cell Degranulation; Cells, Cultured; CHO Cells; Cricetinae; Cyclic AMP; GTP-Binding Proteins; Humans; Kidney; Mast Cells; Purinergic P1 Receptor Agonists; Radioligand Assay; Receptor, Adenosine A2B; Receptors, Purinergic P1; Theophylline; Type C Phospholipases; Xanthines

1999